Validity and Reliability of the Chinese Version of the Diabetes Treatment Burden Questionnaire (DTBQ) Among Patients with Type 2 Diabetes

References

• Hu S, Wang S, Qi C, et al. Cost-utility analysis of once-weekly semaglutide, dulaglutide, and exenatide for type 2 diabetes patients receiving metformin-based background therapy in China. Front Pharmacol. 2022;13:831364. doi:10.3389/fphar.2022.831364
   PubMed Web of Science ®Google Scholar
• Saeedi P, Petersohn I, Salpea P, et al. IDF Diabetes Atlas Committee. Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: results from the international diabetes federation diabetes atlas. Diabetes Res Clin Pract. 2019;157:107843. doi:10.1016/j.diabres.2019.107843
   PubMed Web of Science ®Google Scholar
• Sinclair A, Saeedi P, Kaundal A, Karuranga S, Malanda B, Williams R. Diabetes and global ageing among 65-99-year-old adults: findings from the international diabetes federation diabetes atlas. Diabetes Res Clin Pract. 2020;162:108078. doi:10.1016/j.diabres.2020.108078
   PubMed Web of Science ®Google Scholar
• Zhou M, Wang H, Zhu J, et al. Cause-specific mortality for 240 causes in China during 1990-2013: a systematic subnational analysis for the global burden of disease study 2013. Lancet. 2016;387(10015):251–272. doi:10.1016/S0140-6736(15)00551-6
   PubMed Web of Science ®Google Scholar
• Chen L, Magliano DJ, Zimmet PZ. The worldwide epidemiology of type 2 diabetes mellitus--present and future perspectives. Nat Rev Endocrinol. 2011;(4):228–236. doi:10.1038/nrendo.2011.183
   PubMed Web of Science ®Google Scholar
• American Diabetes Association. Classification and diagnosis of diabetes: standards of medical care in diabetes-2020. Diabetes Care. 2020;43(Suppl1):S14–S31. doi:10.2337/dc20-S002
   PubMedGoogle Scholar
• Ganasegeran K, Hor CP, Jamil MFA, et al. A systematic review of the economic burden of type 2 diabetes in Malaysia. Int J Environ Res Public Health. 2020;17(16):5723. doi:10.3390/ijerph17165723
   PubMed Web of Science ®Google Scholar
• Thrasher J. Pharmacologic management of type 2 diabetes mellitus: available therapies. Am J Cardiol. 2017;120(1S):S4–S16. doi:10.1016/j.amjcard.2017.05.009
   PubMedGoogle Scholar
• Migdal AL, Fortin-Leung C, Pasquel F, Wang H, Peng L, Umpierrez GE. Inpatient glycemic control with sliding scale insulin in noncritical patients with type 2 diabetes: who can slide? J Hosp Med. 2021;16(8):462–468. doi:10.12788/jhm.3654
   PubMed Web of Science ®Google Scholar
• Ali MK, Bullard KM, Saaddine JB, Cowie CC, Imperatore G, Gregg EW. Achievement of goals in U.S. diabetes care, 1999–2010. N Engl J Med. 2013;368(17):1613–1624. doi:10.1056/NEJMsa1213829
   PubMed Web of Science ®Google Scholar
• Bailey CJ, Kodack M. Patient adherence to medication requirements for therapy of type 2 diabetes. Int J Clin Pract. 2011;65(3):314–322. doi:10.1111/j.1742-1241.2010.02544.x
   PubMed Web of Science ®Google Scholar
• García-Pérez LE, Alvarez M, Dilla T, Gil-Guillén V, Orozco-Beltrán D. Adherence to therapies in patients with type 2 diabetes. Diabetes Ther. 2013;4(2):175–194. doi:10.1007/s13300-013-0034-y
   PubMed Web of Science ®Google Scholar
• Islam SM, Biswas T, Bhuiyan FA, Mustafa K, Islam A. Patients’ perspective of disease and medication adherence for type 2 diabetes in an urban area in Bangladesh: a qualitative study. BMC Res Notes. 2017;10(1):131. doi:10.1186/s13104-017-2454-7
   PubMedGoogle Scholar
• Ayele AA, Tegegn HG, Ayele TA, Ayalew MB. Medication regimen complexity and its impact on medication adherence and glycemic control among patients with type 2 diabetes mellitus in an Ethiopian general hospital. BMJ Open Diabetes Res Care. 2019;7(1):e000685. doi:10.1136/bmjdrc-2019-000685
   PubMed Web of Science ®Google Scholar
• Peron EP, Ogbonna KC, Donohoe KL. Antidiabetic medications and polypharmacy. Clin Geriatr Med. 2015;31(1):17–27, vii. doi:10.1016/j.cger.2014.08.017
   PubMed Web of Science ®Google Scholar
• Böhm AK, Schneider U, Aberle J, Stargardt T. Regimen simplification and medication adherence: fixed-dose versus loose-dose combination therapy for type 2 diabetes. PLoS One. 2021;16(5):e0250993. doi:10.1371/journal.pone.0250993
   PubMed Web of Science ®Google Scholar
• Jannuzzi FF, Cornélio ME, São-João TM, Gallani MC, Godin G, Rodrigues RCM. Psychosocial determinants of adherence to oral antidiabetic medication among people with type 2 diabetes. J Clin Nurs. 2020;29(5–6):909–921. doi:10.1111/jocn.15149
   PubMed Web of Science ®Google Scholar
• Blonde L, San Juan ZT, Bolton P. Fixed-dose combination therapy in type 2 diabetes mellitus. Endocr Pract. 2014;20(12):1322–1332. doi:10.4158/EP14259.RA
   PubMed Web of Science ®Google Scholar
• Kalra S, Das AK, Priya G, et al. Fixed-dose combination in management of type 2 diabetes mellitus: expert opinion from an international panel. J Family Med Prim Care. 2020;9(11):5450–5457. doi:10.4103/jfmpc.jfmpc_843_20
   PubMedGoogle Scholar
• Khdour MR, Awadallah HB, Al-Hamed DH. Treatment satisfaction and quality of life among type 2 diabetes patients: a cross-sectional study in west bank, Palestine. J Diabetes Res. 2020;2020:1834534. doi:10.1155/2020/1834534
   PubMed Web of Science ®Google Scholar
• Jia W, Weng J, Zhu D, et al. Standards of medical care for type 2 diabetes in China 2019. Diabetes Metab Res Rev. 2019;35(6):e3158. doi:10.1002/dmrr.3158
   PubMed Web of Science ®Google Scholar
• Ceriello A, deValk HW, Guerci B, et al. The burden of type 2 diabetes in Europe: current and future aspects of insulin treatment from patient and healthcare spending perspectives. Diabetes Res Clin Pract. 2020;161:108053. doi:10.1016/j.diabres.2020.108053
   PubMed Web of Science ®Google Scholar
• Dugani SB, Mielke MM, Vella A. Burden and management of type 2 diabetes in rural United States. Diabetes Metab Res Rev. 2021;37(5):e3410. doi:10.1002/dmrr.3410
   PubMed Web of Science ®Google Scholar
• Bellary S, Kyrou I, Brown JE, Bailey CJ. Type 2 diabetes mellitus in older adults: clinical considerations and management. Nat Rev Endocrinol. 2021;17(9):534–548. doi:10.1038/s41574-021-00512-2
   PubMed Web of Science ®Google Scholar
• Amiel SA, Aschner P, Childs B, et al. International Hypoglycaemia Study Group. Hypoglycaemia, cardiovascular disease, and mortality in diabetes: epidemiology, pathogenesis, and management. Lancet Diabetes Endocrinol. 2019;7(5):385–396. doi:10.1016/S2213-8587(18)30315-2
   PubMed Web of Science ®Google Scholar
• Dennick K, Sturt J, Speight J. What is diabetes distress and how can we measure it? A narrative review and conceptual model. J Diabetes Complications. 2017;31(5):898–911. doi:10.1016/j.jdiacomp.2016.12.018
   PubMed Web of Science ®Google Scholar
• Polonsky WH, Anderson BJ, Lohrer PA, et al. Assessment of diabetes-related distress. Diabetes Care. 1995;18(6):754–760. doi:10.2337/diacare.18.6.754
   PubMed Web of Science ®Google Scholar
• Polonsky WH, Fisher L, Earles J, et al. Assessing psychosocial distress in diabetes: development of the diabetes distress scale. Diabetes Care. 2005;28(3):626–631. doi:10.2337/diacare.28.3.626
   PubMed Web of Science ®Google Scholar
• Katusiime B, Corlett SA, Krska J. Development and validation of a revised instrument to measure burden of long-term medicines use: the living with medicines questionnaire version 3. Patient Relat Outcome Meas. 2018;9:155–168. doi:10.2147/PROM.S151143
   PubMed Web of Science ®Google Scholar
• Andreasen CR, Andersen A, Knop FK, Vilsbøll T. Understanding the place for GLP-1RA therapy: translating guidelines for treatment of type 2 diabetes into everyday clinical practice and patient selection. Diabetes Obes Metab. 2021;23(Suppl3):40–52. doi:10.1111/dom.14500
   PubMedGoogle Scholar
• Kendall JM. Designing a research project: randomised controlled trials and their principles. Emerg Med J. 2003;20(2):164–168. doi:10.1136/emj.20.2.164
   PubMed Web of Science ®Google Scholar
• Ishii H, Shin K, Tosaki T, et al. Reproducibility and Validity of a Questionnaire Measuring Treatment Burden on Patients with Type 2 Diabetes: diabetic Treatment Burden Questionnaire (DTBQ). Diabetes Therapy. 2018;9(3):1001–1019. doi:10.1007/s13300-018-0414-4
   PubMed Web of Science ®Google Scholar
• Beaton DE, Bombardier C, Guillemin F, Ferraz MB. Guidelines for the process of cross-cultural adaptation of self-report measures. Spine. 2000;25(24):3186–3191. doi:10.1097/00007632-200012150-00014
   PubMed Web of Science ®Google Scholar
• Wu ML. Questionnaire Statistical Analysis Practices: SPSS Operation and Application. Chongqing: Chongqing University Press; 2010.
   Google Scholar
• Wu ML. Structural Equation Modeling-AMOS Operation and Application. Chongqing: Chongqing University Press; 2009.
   Google Scholar
• Sun XJ, Zhang GH, Guo CM, et al. Associations between psycho-behavioral risk factors and diabetic retinopathy: NHANES (2005–2018). Front Public Health. 2022;10:966714. doi:10.3389/fpubh.2022.966714
   PubMed Web of Science ®Google Scholar
• Chen C, Song J, Xu X, Zhou L, Wang Y, Chen H. Analysis of influencing factors of economic burden and medical service utilization of diabetic patients in China. PLoS One. 2020;15(10):e0239844. doi:10.1371/journal.pone.0239844
   PubMed Web of Science ®Google Scholar
• Lecomte P, Romon I, Fosse S, Simon D, Fagot-Campagna A. Self-monitoring of blood glucose in people with type 1 and type 2 diabetes living in France: the Entred study 2001. Diabetes Metab. 2008;34(3):219–226. doi:10.1016/j.diabet.2007.11.005
   PubMed Web of Science ®Google Scholar
• Nauck MA, Wefers J, Meier JJ. Treatment of type 2 diabetes: challenges, hopes, and anticipated successes. Lancet Diabetes Endocrinol. 2021;9(8):525–544. doi:10.1016/S2213-8587(21)00113-3
   PubMed Web of Science ®Google Scholar
• Bhat S, Chowta M, Chowta N, Shastry R, Kamath P. The proportion of type 2 diabetic patients achieving treatment goals and the survey of patients’ attitude towards insulin in tiation ini patient s with inadequate glycaemic control with oral anti-diabetic drugs. Curr Diabetes Rev. 2021;17(5):e110620182719. doi:10.2174/1573399816666200611134121
   PubMed Web of Science ®Google Scholar